Literature DB >> 15133853

Immune tolerance in pancreatic islet xenotransplantation.

Tian-Hua Tang1, Chun-Lin Li, Xin Li, Feng-Qin Jiang, Yu-Kun Zhang, Hai-Quan Ren, Shan-Shan Su, Guo-Sheng Jiang.   

Abstract

AIM: To observe the effect of tail vein injection with donor hepatocytes and/or splenocytes on the islet xenotransplantation rejection.
METHODS: New-born male pigs and BALB/C mice were selected as donors and recipients respectively. Islet xenotransplantation was performed in recipients just after the third time of tail vein injection with donor hepatocytes and/or splenocytes. Macrophage phagocytosis, NK(natural killing cell) killing activity, T lymphocyte transforming function of spleen cells, antibody forming function of B lymphocytes, and T lymphocyte subsets were taken to monitor transplantation rejection. The effects of this kind of transplantation were indicated as variation of blood glucose and survival days of recipients.
RESULTS: The results showed that streptozotocin (STZ) could induce diabetes mellitus models of mice. The pre-injection of donor hepatocytes, splenocytes or their mixture by tail vein injection was effective in preventing donor islet transplantation from rejection, which was demonstrated by the above-mentioned immunological marks. Each group of transplantation could decrease blood glucose in recipients and increase survival days. Pre-injection of mixture of donor hepatocytes and splenocytes was more effective in preventing rejection as compared with that of donor hepatocyte or splenocyte pre-injection respectively.
CONCLUSION: Pre-injection of donor hepatocytes, splenocytes or their mixture before donor islet transplantation is a good way in preventing rejection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133853      PMCID: PMC4656284          DOI: 10.3748/wjg.v10.i10.1457

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Effects of graft-versus-host reaction on intrahepatic islet transplants.

Authors:  H Li; C Ricordi; L Inverardi
Journal:  Diabetes       Date:  1999-12       Impact factor: 9.461

Review 2.  Factors influencing Islet of Langerhans graft function and monitoring.

Authors:  A Pileggi; C Ricordi; M Alessiani; L Inverardi
Journal:  Clin Chim Acta       Date:  2001-08-01       Impact factor: 3.786

3.  [Biocompatibility testing and function of a pancreatic prosthesis consisting of viable pancreatic islets encapsulated in PVA macrocapsules].

Authors:  E Gamian; A Kochman; J Rabczyński; K Burczak
Journal:  Polim Med       Date:  1999

4.  Induction of allogeneic islet tolerance in a large-animal model.

Authors:  P J Horton; W J Hawthorne; S N Walters; A T Patel; P J O'Connell; J R Chapman; R D Allen
Journal:  Cell Transplant       Date:  2000 Nov-Dec       Impact factor: 4.064

5.  Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.

Authors:  Y Nakafusa; J A Goss; T Mohanakumar; M W Flye
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

6.  Isolation of porcine pancreatic islets: low trypsin activity during the isolation procedure guarantees reproducible high islet yields.

Authors:  A Heiser; K Ulrichs; W Müller-Ruchholtz
Journal:  J Clin Lab Anal       Date:  1994       Impact factor: 2.352

7.  Sequential transplantation induces islet allograft tolerance.

Authors:  J Sun; X Wang; C Wang; A G Sheil
Journal:  Microsurgery       Date:  2001       Impact factor: 2.425

8.  Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells.

Authors:  Y M Deng; B E Tuch; W D Rawlinson
Journal:  Transplantation       Date:  2000-10-15       Impact factor: 4.939

9.  Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells.

Authors:  O O Oluwole; H A Depaz; R Gopinathan; A Ali; M Garrovillo; M X Jin; M A Hardy; S F Oluwole
Journal:  Diabetes       Date:  2001-07       Impact factor: 9.461

10.  Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation or by injection with T-enriched splenocytes.

Authors:  S K Smyk-Pearson; A C Bakke; P K Held; R S Wildin
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.